The Relationship between Pre-Anesthetic Analgesia and Nociception (ANI) and Propofol Injection Pain among Patients Receiving Remifentanil: A Prospective, Randomized, Controlled Study.
Cheolhyeong LeeCheol LeeJunsung LimJeongki ParkJaehak JungHayoung LeeMyeong Jong LeePublished in: Medicina (Kaunas, Lithuania) (2024)
Background and Objectives : The analgesia/nociception index (ANI) potentially monitors nociceptive status during anesthesia, but its link to preoperative pain sensitivity is unclear. We investigated the relationship between pre-anesthetic ANI scores and propofol injection pain (PIP) in patients receiving remifentanil. Materials and Methods : This study included 124 male patients aged 19-60 undergoing general anesthesia (ASA class I or II). Patients were randomized to group R ( n = 62, remifentanil 4 ng/mL) or group C ( n = 62, saline). The primary outcome was the association between PIP and ANI. Secondary outcomes included the incidence and severity of PIP or rocuronium-induced withdrawal movement (RIWM) and their association with ANI. Results : PIP and RIWM incidence and severity were lower in group R than in group C. A weak negative correlation between PIP and ANI at pre-induction (r pb = -0.21, p = 0.02, r pb = -0.37, p < 0.01) and a moderate negative correlation during propofol injection ( r pb = -0.48, p = 0.02) were observed. A significant negative correlation was found between RIWM and ANI during rocuronium injection (τb = -0.61, p < 0.01). AUC, cut-off value, specificity, and sensitivity in ANI at pre-induction for predicting PIP were 0.67 ( p = 0.02), 59, 76%, and 55%, respectively. AUC, cut-off value, specificity, and sensitivity in ANI during propofol injection for PIP were 0.77 ( p < 0.01), 65, 81%, and 67%, respectively. Conclusions : ANI scores demonstrated significant differences between groups, suggesting potential predictive value for PIP despite the low pre-induction AUC value. This study highlights the potential of using ANI scores to predict and manage PIP in patients receiving remifentanil.
Keyphrases
- ultrasound guided
- pain management
- end stage renal disease
- chronic pain
- ejection fraction
- newly diagnosed
- chronic kidney disease
- neuropathic pain
- heavy metals
- risk factors
- peritoneal dialysis
- postoperative pain
- risk assessment
- type diabetes
- adipose tissue
- double blind
- endothelial cells
- high glucose
- oxidative stress
- high resolution
- mass spectrometry
- insulin resistance
- metabolic syndrome
- climate change
- high intensity
- patient reported
- single molecule
- high speed